Market Cap 4.15B
Revenue (ttm) 949.25M
Net Income (ttm) 64.09M
EPS (ttm) N/A
PE Ratio 37.51
Forward PE 36.13
Profit Margin 6.75%
Debt to Equity Ratio 0.56
Volume 255,700
Avg Vol 647,202
Day's Range N/A - N/A
Shares Out 35.78M
Stochastic %K 80%
Beta 1.59
Analysts Sell
Price Target $133.00

Company Profile

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast...

Industry: Scientific & Technical Instruments
Sector: Technology
Phone: 781 266 5700
Address:
125 Middlesex Turnpike, Bedford, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:24 AM
Actionable Trade Alert for $NOVT: Market Context: $NOVT is currently trading at $117.42, showing strong momentum with an RSI of 62.62, indicating bullish sentiment but nearing overbought territory. The stock is above both the 30-day MA (114.77) and 50-day MA (110.67), suggesting a positive trend. The recent 60-day high of 137.35 indicates potential upside. Directional Bias: Bullish. The stock's position above key moving averages and the recent high suggests upward momentum. However, the RSI indicates caution as it approaches overbought levels. Trade Plan: - Suggested Entry: $118.00 - Stop Loss: $113.00 (4.27% below entry) - Take Profit Targets: 1. $125.00 (5.93% gain) 2. $135.00 (14.41% gain) 3. $138.00 (17.53% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any shifts in market sentiment. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:59 PM
Actionable Trade Alert for $NOVT: Market Context: $NOVT is currently trading at $117.42, showing strong momentum with an RSI of 62.62, indicating bullish sentiment but nearing overbought territory. The stock is above both the 30-day MA (114.77) and 50-day MA (110.67), suggesting a positive trend. The recent 60-day high of 137.35 indicates potential upside. Directional Bias: Bullish. The stock's position above key moving averages and the recent high suggests upward momentum. However, the RSI indicates caution as it approaches overbought levels. Trade Plan: - Suggested Entry: $118.00 - Stop Loss: $113.00 (4.27% below entry) - Take Profit Targets: 1. $125.00 (5.93% gain) 2. $135.00 (14.41% gain) 3. $138.00 (17.53% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any shifts in market sentiment. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Dec. 4 at 9:01 PM
Wall St is expecting 0.89 EPS for $NOVT Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/novt?chart=historical&metric_name=eps&utm_co
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 9:45 AM
$NOVT Outstanding article that hits the mark on NOVT's current state. So if you want to refresh your NOVT insights or learn about NOVT from scratch, this is a must read. https://beyondspx.com/quote/NOVT/analysis/novanta-s-precision-edge-powering-growth-in-ai-robotics-and-advanced-surgery-nasdaq-novt
0 · Reply
shark1989
shark1989 Nov. 10 at 12:23 PM
$NOVT it’s on the list again toady!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 10:33 PM
0 · Reply
shark1989
shark1989 Nov. 7 at 12:56 AM
$NOVT my data shows tomorrow after open this stock has an 80% chance to close 1.36% higher than the open tomorrow. Take that information where you want it. Happy trading!
0 · Reply
Dauphinoise
Dauphinoise Nov. 6 at 9:11 PM
$NOVT Oh do fuck off 🖕🏻🖕🏻🖕🏻
0 · Reply
Dauphinoise
Dauphinoise Nov. 6 at 6:13 PM
$NOVT How it feels holding this stock…ffs
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:07 PM
0 · Reply
Latest News on NOVT
5 Tech And Consumer Stocks At Risk Of Steep Declines

Nov 12, 2025, 2:53 PM EST - 25 days ago

5 Tech And Consumer Stocks At Risk Of Steep Declines

POWI SFM SNPS VERX


Novanta Inc. Announces Offering of Tangible Equity Units

Nov 5, 2025, 4:12 PM EST - 4 weeks ago

Novanta Inc. Announces Offering of Tangible Equity Units


Novanta Inc. (NOVT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 2:06 PM EST - 4 weeks ago

Novanta Inc. (NOVT) Q3 2025 Earnings Call Transcript


Novanta Hosts ISO event for Humanoid Robot Safety Standards

Oct 24, 2025, 11:00 AM EDT - 6 weeks ago

Novanta Hosts ISO event for Humanoid Robot Safety Standards


Novanta (NOVT) Q2 Revenue Rises 2.2%

Aug 5, 2025, 5:55 PM EDT - 4 months ago

Novanta (NOVT) Q2 Revenue Rises 2.2%


Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:22 PM EDT - 4 months ago

Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript


Novanta Announces Financial Results for the Second Quarter 2025

Aug 5, 2025, 6:55 AM EDT - 4 months ago

Novanta Announces Financial Results for the Second Quarter 2025


Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:50 PM EDT - 7 months ago

Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript


Novanta Announces Financial Results for the First Quarter 2025

May 6, 2025, 7:00 AM EDT - 7 months ago

Novanta Announces Financial Results for the First Quarter 2025


Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 3:36 PM EST - 10 months ago

Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript


Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 1:47 PM EST - 1 year ago

Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript


Novanta Inc. (NOVT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 2:45 PM EDT - 1 year ago

Novanta Inc. (NOVT) Q2 2024 Earnings Call Transcript


Novanta Inc. (NOVT) Q1 2024 Earnings Call Transcript

May 7, 2024, 3:48 PM EDT - 1 year ago

Novanta Inc. (NOVT) Q1 2024 Earnings Call Transcript


Novanta Inc. (NOVT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 3:52 PM EST - 1 year ago

Novanta Inc. (NOVT) Q4 2023 Earnings Call Transcript


Novanta completes acquisition of Motion Solutions

Jan 2, 2024, 4:15 PM EST - 2 years ago

Novanta completes acquisition of Motion Solutions


Novanta announces agreement to acquire Motion Solutions

Nov 14, 2023, 4:13 PM EST - 2 years ago

Novanta announces agreement to acquire Motion Solutions


Novanta, Inc. (NOVT) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:23 PM EST - 2 years ago

Novanta, Inc. (NOVT) Q3 2023 Earnings Call Transcript


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:24 AM
Actionable Trade Alert for $NOVT: Market Context: $NOVT is currently trading at $117.42, showing strong momentum with an RSI of 62.62, indicating bullish sentiment but nearing overbought territory. The stock is above both the 30-day MA (114.77) and 50-day MA (110.67), suggesting a positive trend. The recent 60-day high of 137.35 indicates potential upside. Directional Bias: Bullish. The stock's position above key moving averages and the recent high suggests upward momentum. However, the RSI indicates caution as it approaches overbought levels. Trade Plan: - Suggested Entry: $118.00 - Stop Loss: $113.00 (4.27% below entry) - Take Profit Targets: 1. $125.00 (5.93% gain) 2. $135.00 (14.41% gain) 3. $138.00 (17.53% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any shifts in market sentiment. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:59 PM
Actionable Trade Alert for $NOVT: Market Context: $NOVT is currently trading at $117.42, showing strong momentum with an RSI of 62.62, indicating bullish sentiment but nearing overbought territory. The stock is above both the 30-day MA (114.77) and 50-day MA (110.67), suggesting a positive trend. The recent 60-day high of 137.35 indicates potential upside. Directional Bias: Bullish. The stock's position above key moving averages and the recent high suggests upward momentum. However, the RSI indicates caution as it approaches overbought levels. Trade Plan: - Suggested Entry: $118.00 - Stop Loss: $113.00 (4.27% below entry) - Take Profit Targets: 1. $125.00 (5.93% gain) 2. $135.00 (14.41% gain) 3. $138.00 (17.53% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any shifts in market sentiment. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Dec. 4 at 9:01 PM
Wall St is expecting 0.89 EPS for $NOVT Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/novt?chart=historical&metric_name=eps&utm_co
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 9:45 AM
$NOVT Outstanding article that hits the mark on NOVT's current state. So if you want to refresh your NOVT insights or learn about NOVT from scratch, this is a must read. https://beyondspx.com/quote/NOVT/analysis/novanta-s-precision-edge-powering-growth-in-ai-robotics-and-advanced-surgery-nasdaq-novt
0 · Reply
shark1989
shark1989 Nov. 10 at 12:23 PM
$NOVT it’s on the list again toady!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 10:33 PM
0 · Reply
shark1989
shark1989 Nov. 7 at 12:56 AM
$NOVT my data shows tomorrow after open this stock has an 80% chance to close 1.36% higher than the open tomorrow. Take that information where you want it. Happy trading!
0 · Reply
Dauphinoise
Dauphinoise Nov. 6 at 9:11 PM
$NOVT Oh do fuck off 🖕🏻🖕🏻🖕🏻
0 · Reply
Dauphinoise
Dauphinoise Nov. 6 at 6:13 PM
$NOVT How it feels holding this stock…ffs
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:07 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:06 PM
0 · Reply
DonCorleone77
DonCorleone77 Nov. 3 at 10:09 PM
$NOVT Novanta reports Q3 adjusted EPS 87c, consensus 82c -- Q3 revenue $247.8M, consensus $245.95M. -- Sees Q4 adjusted EPS 87c-93c, consensus 94c. -- Sees Q4 revenue $253M-$257M, consensus $255.17M. -- Narrows FY25 adjusted EPS $3.24-$3.30 from $3.22-$3.36, consensus $3.26. -- Narrows FY25 revenue view to $975M-$979M from $970M-$985M, consensus $975.56M.
0 · Reply
DeepTradeMind
DeepTradeMind Oct. 5 at 2:07 PM
$NOVT Technology hardware consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength.
0 · Reply
temps425
temps425 Sep. 12 at 4:21 AM
$NOVT even insides sold this down the river. Run
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 7:19 PM
$NOVT Outstanding article that hits the mark on NOVT's current state. So if you want to refresh your NOVT insights or learn about NOVT from scratch, this is a must read. https://beyondspx.com/quote/NOVT/analysis/novanta-s-precision-edge-powering-growth-through-ai-robotics-and-medical-innovation-novt
0 · Reply
Dauphinoise
Dauphinoise Aug. 15 at 7:53 PM
This is what $NOVT feels like currently…
0 · Reply
Dauphinoise
Dauphinoise Aug. 14 at 7:34 PM
$NOVT Yet again you’re acting like a meme?!
0 · Reply
Estimize
Estimize Aug. 13 at 10:00 AM
Wall St is expecting 0.82 EPS for $NOVT Q3 [Reporting 11/11 BMO] http://www.estimize.com/intro/novt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 1:01 PM
Baird has adjusted their stance on Novanta ( $NOVT ), setting the rating to Neutral with a target price of 139 → 133.
0 · Reply
PaperHandsClub
PaperHandsClub Aug. 6 at 1:51 PM
$NOVT Industrial tech breaking ascending triangle at $230. Volume confirmation validates pattern. Next resistance at $250 (psych level), support at $225.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 5 at 11:03 AM
$NOVT Novanta reports Q2 adjusted EPS 76c, consensus 73c -- Q2 revenue $241M, consensus $237.97M. -- Novanta sees Q3 adjusted EPS 78c-85c, consensus 93c -- Sees Q3 revenue $244M-$247M, consensus $254.56M. -- Sees FY25 adjusted EPS $3.22-$3.36, consensus $3.37 -- Sees FY25 revenue $970M-$985M, consensus $983.16M.
0 · Reply
ChessGM
ChessGM Aug. 2 at 3:22 AM
$NOVT "Heads up alert! Upcoming earnings on Tuesday, 8/5/2025 for $NOVT Bearish (3.2) Financial Analysis: Novanta Inc. (NASDAQ: NOVT) is currently experiencing a challenging phase, with its stock reflecting a downtrend over the past six months, declining by 10.8%, which contrasts starkly with the S&P 500's gain of 6.9% during the same period. Despite these setbacks, Novanta has demonstrated certain fundamental strengths. The company's recent quarterly earnings aligned with Wall Street's revenue expectations, showcasing resilience in its core operations. Notably, the Advanced Surgery unit has been a key growth driver, bolstered by robust new product launches in minimally invasive surgery and robotics. However, concerns persist regarding the stock's valuation and market performance. Novanta's Price-to-Earnings (P/E) ratio has been higher than the industry average, which may indicate overvaluation, especially given the recent stock price decline. Earnings Per Share (EPS) growth has shown some positive trends, but investors remain cautious due to broader market volatility and specific sector challenges. When compared to industry peers, Novanta's performance appears subdued, necessitating a closer examination of strategic initiatives aimed at revitalizing market confidence and shareholder value. Upcoming Earnings Report: Novanta is scheduled to release its second-quarter 2025 earnings on August 5, 2025. Historically, the company has managed to meet or slightly exceed analyst expectations, thanks to its strong operational framework and strategic investments in technology and product innovation. Analyst consensus estimates for the upcoming earnings report suggest moderate revenue growth, driven by advancements in the Advanced Surgery segment and continued emphasis on minimally invasive surgical solutions. However, the market will closely monitor any guidance provided by management regarding macroeconomic headwinds and their potential impact on future performance. The upcoming earnings release will be pivotal, as it could either reinforce investor confidence or further exacerbate existing concerns about the stock's trajectory. Sector Performance: Novanta operates within the electronic components sector, which has recently seen mixed performance. While some companies, like Corning, have showcased strong quarterly results, others have struggled to maintain momentum amid global supply chain disruptions and fluctuating demand dynamics. The sector's overall performance has been influenced by technological advancements and shifts in consumer behavior, but challenges such as rising material costs and geopolitical uncertainties continue to pose risks. Investors are keenly observing sector trends to identify opportunities and mitigate potential downsides, with a focus on companies that exhibit robust innovation capabilities and market adaptability. - Funds were net buyers of $NOVT during the previous reporting quarter. - Funds with large holdings in $NOVT include: - Conestoga Capital Advisors LLC, MV: $175MM. Fund Rank: 67% - GW&K Investment Management LLC, MV: $43MM. Fund Rank: 75% - Clearline Capital LLC, MV: $17MM. New position. Fund Rank: 72% www.clearlinecap.com - Telemark Asset Management LLC, MV: $12MM. Fund Rank: 80% - Southpoint Capital Advisors LP, MV: $9MM. New position. Fund Rank: 89% www.southpointcapital.com - Last 10 days performance: -1% - Last 30 days performance: -7% - Last 90 days performance: 1% Some of the latest news articles: - Title: Stocks to watch next week: BP, Diageo, Disney, Uber and WPP Publication Date: 8/1/2025 3:38:41 PM, Source: yahoo URL: https://uk.finance.yahoo.com/news/bp-diageo-disney-uber-wpp-stocks-watch-153517077.html?.tsrc=rss - Title: Shareholders in Novanta (NASDAQ:NOVT) are in the red if they invested a year ago Publication Date: 7/31/2025 10:09:47 AM, Source: yahoo URL: https://finance.yahoo.com/news/shareholders-novanta-nasdaq-novt-red-100947184.html?.tsrc=rss - Title: Jim Cramer on Crocs: “There’s No Sin in Saying It’s Too Hard” Publication Date: 7/12/2025 3:20:58 PM, Source: yahoo URL: https://finance.yahoo.com/news/jim-cramer-crocs-no-sin-152058589.html?.tsrc=rss - Title: 3 Reasons NOVT is Risky and 1 Stock to Buy Instead Publication Date: 7/9/2025 4:07:45 AM, Source: yahoo URL: https://finance.yahoo.com/news/3-reasons-novt-risky-1-040745531.html?.tsrc=rss Follow us on stocktwits.com and Substack (chessgmstocks.substack.com). Not a financial advice. Not a trading signal."
0 · Reply